The Story Of Our Firm | En Français | En Español
 Home    Lawyers   Litigation   Contact Us   Verdicts   Search

Personal Injury Injuries Dangerous Products Research Center

FDA Product Recall Policy

in this section: Breaking News | Toy Recall News | Risky Business | FDA Product Recall Policy | Dangerous Toys | Dangerous Gear | Radiation Man


Bookmark This Page Print This Page Email This Page

FDA Recall Policies


The recall of a defective or possibly harmful consumer product often is highly publicized in newspapers and on news broadcasts. This is especially true when a recall involves foods, drugs, cosmetics, medical devices, and other products regulated by FDA. Despite this publicity, FDA's role in recall activities is often misunderstood not only by consumers, but also by the news media, and occasionally even by the regulated industry. The following headlines, which appeared in two major daily newspapers, are good examples of that misunderstanding: "FDA Orders Peanut Butter Recall," and "FDA Orders 6,500 Cases of Red-Dyed Mints Recalled."


The headlines are wrong in indicating that the Agency can "order" these recalls. The Federal Food, Drug, and Cosmetic Act, (the law) does not generally authorize FDA to "order" a manufacturer to recall a food, cosmetic or supplement. The agency may request a product recall if the firm is not willing to remove dangerous products from the market without FDA's written request. Only when a medical device, human tissue products, and infant formula pose a risk to human health; that the law specifically authorizes FDA to prescribe a recall and to rule on the scope and extent of the same*.


The manufacturers or distributors of the product carry out most recalls of products regulated by FDA voluntarily. In some instances, a company discovers that one of its products is defective and recalls it entirely on its own. In others, FDA informs a company of findings that one of its products is defective and suggests or requests a recall. Usually, the company will comply.


If the firm does not recall the product, then FDA can seek legal action under the FD&C Act. These include seizure of available product, and/or injunction of the firm, including a court request for recall of the product.
This cooperation between FDA and its regulated industries has proven over the years to be the quickest and most reliable method to remove potentially dangerous products from the market. This method has been successful because it is in the interest of FDA, as well as industry, to get unsafe and defective products out of consumer hands as soon as possible.


FDA guidelines for companies to follow when recalling defective products under the Agency's jurisdiction are published in Title 21 of the Code of Federal Regulations, Part 7. These guidelines make clear that FDA expects these firms to take full responsibility for product recalls, including follow-up checks to assure that recalls are successful. Under the guidelines, companies are expected to notify FDA when recalls are started, to make progress reports to FDA on recalls, and to undertake recalls when asked to do so by the Agency.


The guidelines also call on manufacturers and distributors to develop contingency plans for product recalls that can be put into effect if, and when needed. FDA's role under the guidelines is to monitor company recalls and assess the adequacy of a firm's action. After a recall is completed, FDA makes sure that the product is destroyed or suitably reconditioned and investigates why the product was defective.
Generally, FDA accepts reports and other necessary recall information submitted by e-mail. In many cases, this has become routine for some firms and FDA district offices. However, FDA maintains the prerogative for investigational visits and other in-person communications where the agency considers it appropriate.


The guidelines categorize all recalls into one of three classes according to the level of hazard involved.
Class I recalls are for dangerous or defective products that predictably could cause serious health problems or death. Examples of products that could fall into this category are a food found to contain botulinal toxin, food with undeclared allergens, a label mix-up on a life saving drug, or a defective artificial heart valve.


Class II recalls are for products that might cause a temporary health problem, or pose only a slight threat of a serious nature. One example is a drug that is under-strength but that is not used to treat life-threatening situations.


Class III recalls are for products that are unlikely to cause any adverse health reaction, but that violate FDA labeling or manufacturing regulations. Examples might be a container defect (plastic material delaminating or a lid that does not seal); off-taste, color, or leaks in a bottled drink, and lack of English labeling in a retail food.


FDA develops a strategy for each individual recall that sets forth how extensively it will check on a company's performance in recalling the product in question. For a Class I recall, for example, FDA would check to make sure that each defective product has been recalled or reconditioned. In contrast, for a Class III recall, the Agency may decide that it only needs to spot check to make sure the product is off the market.


Even though the firm recalling the product may issue a press release, FDA seeks publicity about a recall only when it believes the public needs to be alerted about a serious hazard. For example, if a canned food product, purchased by a consumer at a retail store, were found by FDA to contain botulinal toxin, an effort would be made to retrieve all the cans in circulation, including those in the hands of consumers. As part of this effort, the Agency also could issue a public warning via the news media to alert as many consumers as possible to the potential hazard.
FDA also issues general information about new recalls it is monitoring through FDA Enforcement Reports, a weekly publication available in FDA's Internet page at: http://www.fda.gov/


The Enforcement Reports are also available for purchase from Government Printing Office bookstores across the U.S. Consult the telephone book for one nearest you; or visit them on the Internet at http://www.gpo.gov. For additional information on recalls, contact the FDA District Office nearest you.


*Sec. 412, and Sec. 518, Food Drug and Cosmetic Act; Sec. 351 Public Health Service Act.

'
see also:

Risky Business FREE article about product liability
Read an article on product liability titled "Risky business: before a defective product becomes your downfall, learn how to protect yourself"

Breaking News Product Liability Resources: Product Liability Breaking News
Product Liability Resources: Breaking News about Product Liability

News & Warnings Product Liability in the News--Free Case Evaluation and Lawsuit Info
News on Product Liability Cases and Verdicts--Free Lawyer Review

Name
Phone
Email
Do you have a legal question? Ask us!    strictly confidential
Your Question
  • MESOTHELIOMA
    • Mesothelioma Treatment
    • Mesothelioma Symptoms
    • Lung Cancer
    • Help for Veterans
    • Asbestos Exposure
    • Your Legal Options
    • Mesothelioma Lawyer
    • Asbestos Cancer
  • DEFECTIVE MEDICINES AND DEVICES
      Actos
      DePuy Hip
      Fosamax
    • Accutane
    • Avandia
    • Depakote
    • Gadolinium
    • Hydroxycut
    • Paxil Birth Defects
    • Qui Tam
    • Reglan
    • Shoulder Pain Pumps
    • Topamax
    • Pelvic Mesh
    • Yaz/Yasmin/Ocella
    • Zimmer Durom
    • Zimmer NexGen-CR Flex Porous Femoral component
    • Zimmer LPS-Flex
    • Zoloft Birth Defects
  • ENTERTAINMENT LAW
    • Intellectual Property
    • Creative Rights
    • Royalties
    • Licensing Fees
    • Breach of Contract
    • Fraud
  • ENVIRONMENTAL POLLUTION
    • Arsenic
    • Benzene
    • Chromium
    • Dioxins
    • Gulf Oil Spill
    • Landfill Odors
    • Lead Poisoning
    • Mercury Poisoning
    • Pesticides
    • Petroleum Spills
    • PCB
    • Property Damage
    • Radium
    • TCE
    • Water Contamination
    • Vapor Intrusion
  • ACCIDENTS
    • Auto Accident
    • Car Accident
    • Elevator Accident
    • Truck Accident
    • Workplace Accident
    • Pedestrian Knock-down
    • Bicyclist Collision
    • Motorcycle Collision
    • Single-Car Collision
    • Toyota Recall
    • Two-Car Collision
    • Multi-Car Collision
  • PERSONAL INJURY
    • Aviation
    • Back Injury
    • Birth Defects
    • Burn Injury
    • Brain Injury
    • Eye Injury
    • Life Insurance Law
    • Nursing Home Abuse
    • Spinal Cord Injury
    • Wrongful Death
    • Product Liability
    • Assault
    • Battery
    • Dog Bite
    • Stray Electricity
  • MEDICAL MALPRACTICE
    • New York Medical Malpractice
    • Anesthesia Complications
    • Birth Injury
    • Brachial Plexus Palsy
    • Cancer Misdiagnosis
    • Cerebral Palsy
    • Death
    • Erb’s Palsy
    • Failure to Diagnose
    • Foreign Object
    • Hospital Error
    • Hydrocephalus
    • Informed Consent
    • Medication Error
    • Pain and Suffering
    • Paraplegia
    • Podiatric Malpractice
    • Quadriplegia
    • Surgical Error
Name:
Phone:
Email:
Case Description:


$423 million settlement
MTBE suit involving the contamination of 153 public water systems nationally
$16.5 million verdict
Asbestos case involving exposure from dental tape
$1.4 million settlement
Accident involving woman struck down by ambulance
$1.5 million settlement
for 47-year-old construction worker who fell off elevated train tracks
$6 million settlement
Pediatric malpractice involving infant who suffered brain damage at birth
$53 million verdict
brake mechanic suffering from mesothelioma
$13.5 million verdict
one of the very first Vioxx trial cases
$15 million settlement
man wound up a paraplegic due to negligent hospital care
$37 million verdict
2 asbestos lung cancer plaintiffs
$47 million verdict
boilermaker who died from mesothelioma
$2.6 million settlement
ill-fitting prosthesis caused decubitus ulcers
$75 million verdict
historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s
$8 million settlement
obstetrical malpractice resulted in neurological deficits
$64.65 million award
4 asbestos plaintiffs
$17.5 million
consolidated trial of 5 mesothelioma victims
Ask a Free Question:
Were you injured?
check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases,

get the compensation to which they’re entitled and continue with their lives. In just over 25 years, we’ve collected more than $7 billion for plaintiffs.

Copyright © 2012 Weitz & Luxenberg, 700 Broadway, New York, NY 10003

Wi3 Prior results do not guarantee a similar outcome.
HOME | DISCLAIMER | SITE MAP | CONTACT US |NEWS CENTER | CAREERS